This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Irving H. Fox, MD; William N. Kelley, MD

JAMA. 1979;242(4):361-364.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

GOUT is a term describing a heterogeneous group of diseases that, in full development, are manifested by (1) an increase in the serum urate concentration, (2) recurrent attacks of a characteristic type of acute arthritis in which crystals of monosodium urate monohydrate are demonstrable in leukocytes of synovial fluid, (3) aggregate deposits of monosodium urate monohydrate (tophi) occurring chiefly in and around the joints of the extremities and sometimes leading to severe crippling and deformity, (4) renal disease of uncertain cause that involves glomeruli, tubules, interstitial tissues, and blood vessels, and (5) uric acid urolithiasis.¹ These manifestations may occur in different combinations.

The objective of treatment is to terminate an acute attack rapidly as well as to prevent future attacks of gout, to lower the serum urate concentration to prevent its accumulation in body tissues, to prevent the formation of uric acid calculi, and to treat disorders accompanying hyperuricemia, eg, . . . [Full Text PDF of this Article]

Author Affiliations
From the Departments of Internal Medicine (Drs Fox and Kelley) and Biological Chemistry (Drs Fox and Kelley), The Human Purine Research Center, University of Michigan Medical Center, Ann Arbor.

Footnotes
Reprint requests to Department of Internal Medicine, University Hospital, Ann Arbor, MI 48109 (Dr Fox).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?